Host and parasite factors influencing P. vivax RBC invasion and asexual development
影响间日疟原虫红细胞侵袭和无性发育的宿主和寄生虫因素
基本信息
- 批准号:10641026
- 负责人:
- 金额:$ 70.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-08 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AntibodiesAntigensAreaBindingBiologyBloodBlood specimenCambodiaCambodianCell Cycle ProgressionCell physiologyCell surfaceCellsCellular Indexing of Transcriptomes and Epitopes by SequencingCharacteristicsCollaborationsComplementDNADataDevelopmentErythrocytesExposure toFoundationsG6PD geneGene ExpressionGene Expression ProfileGene Expression ProfilingGenetic PolymorphismGenomic approachGenotypeGeographic DistributionGlucosephosphate Dehydrogenase DeficiencyGrowthHemoglobinHemoglobinopathiesHumanImmuneImmunityIn VitroIndividualInfectionInflammationInvadedLeukocytesMalariaMalaria VaccinesMeasuresMolecularParasitemiaParasitesParticipantPathway interactionsPatientsPeripheral Blood Mononuclear CellPhenotypePlasmodiumPlasmodium vivaxPopulationPredispositionProcessProteinsRNARegulationRoleSamplingSerologySeverity of illnessSex DifferentiationSolidSymptomsTestingTranscriptional RegulationVariantVivax MalariaWhole Bloodacquired immunityasexualclinically relevantcytokinedensityexperienceexperimental studygenome-widehuman pathogenimprovedin vivoinsightnovelparasite invasionpatient subsetspreventresilienceresponsesingle-cell RNA sequencingtranscriptometranscriptome sequencingtranscriptomicsvaccine trial
项目摘要
Abstract
Plasmodium vivax threatens half of the world’s population and is surprisingly resilient to on-going malaria
elimination efforts, partially due to its unique characteristics and our poor understanding of its biology. Here, we
propose to conduct state-of-the-art transcriptomic analyses using materials derived directly from Cambodian
patients to rigorously assess the importance of red blood cell polymorphisms, host immunity and parasite factors
in modulating the efficacy of red blood cell invasion and P. vivax intraerythrocytic development. Our studies will
not only provide a better understanding of the fundamental molecular and cellular processes underlying blood
stage P. vivax infections but will also provide a solid foundation to develop better malaria vaccines against this
important but understudied human pathogen.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Serre其他文献
David Serre的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Serre', 18)}}的其他基金
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
间日疟原虫休眠子的多组学表征
- 批准号:
10565802 - 财政年份:2022
- 资助金额:
$ 70.63万 - 项目类别:
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array
间日疟原虫超密集肽阵列的设计和评估
- 批准号:
10372166 - 财政年份:2021
- 资助金额:
$ 70.63万 - 项目类别:
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array
间日疟原虫超密集肽阵列的设计和评估
- 批准号:
10189044 - 财政年份:2021
- 资助金额:
$ 70.63万 - 项目类别:
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure
严格评估间日疟原虫复发和伯氨喹根治疗效
- 批准号:
10469663 - 财政年份:2020
- 资助金额:
$ 70.63万 - 项目类别:
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure
严格评估间日疟原虫复发和伯氨喹根治疗效
- 批准号:
10219069 - 财政年份:2020
- 资助金额:
$ 70.63万 - 项目类别:
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure
严格评估间日疟原虫复发和伯氨喹根治疗效
- 批准号:
10657543 - 财政年份:2020
- 资助金额:
$ 70.63万 - 项目类别:
Host and Parasite Transcriptional Changes Associated with Immunity to Clinical Malaria in Malian Children
与马里儿童临床疟疾免疫相关的宿主和寄生虫转录变化
- 批准号:
9812115 - 财政年份:2019
- 资助金额:
$ 70.63万 - 项目类别:
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia
柬埔寨间日疟原虫对抗疟药物反应的基因组分析
- 批准号:
9254424 - 财政年份:2013
- 资助金额:
$ 70.63万 - 项目类别:
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia
柬埔寨间日疟原虫对抗疟药物反应的基因组分析
- 批准号:
9398175 - 财政年份:2013
- 资助金额:
$ 70.63万 - 项目类别:
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia
柬埔寨间日疟原虫对抗疟药物反应的基因组分析
- 批准号:
8576980 - 财政年份:2013
- 资助金额:
$ 70.63万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 70.63万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 70.63万 - 项目类别:














{{item.name}}会员




